Alberta Star Dev (ASXSF) 0.2500 $ASXSF ELYSEE Acquires

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Alberta Star Dev (ASXSF) 0.2500 $ASXSF

ELYSEE Acquires 1.3 Million Units of IBC Alloys Corp, Provides Corporate Update
ACCESSWIRE - Mon May 30, 6:20AM CDT
VANCOUVER, BC / ACCESSWIRE / May 30, 2016 / Elysee Development Corp. (TSXV: ELC) is pleased to announce that it has acquired 1.3 Million units of IBC Alloys Corp. at $0.375 per unit for a total investment of $487,500 and 232,500 units of Alexco Resource Corp. at $1.20 per unit for $279,000. These investments represent approximately 5% and 3% respectively of our total investment portfolio.IBC Advanced Alloys Corp. is an advanced alloys and precision castings company serving a variety of industries including nuclear energy, automotive, telecommunications and a range of industrial applications. Advanced alloys utilizing rare metals, including beryllium, are produced for a range of specialized applications, with IBC currently supplying specialized beryllium-aluminum cast alloy parts for the F-35 Joint Strike Fighter program in the U.S.Alexco Resource Corp. owns the historic Keno Hill Silver District in the Yukon which includes the high grade Bellekeno silver mine, which is now on interim suspension. Alexco is exploring other promising high-grade silver prospects on its other District properties, and has discovered two important new deposits - the Flame & Moth and Bermingham, with significant high-grade drill intercepts reported from Bermingham in 2014 and followed up during 2015.During the three month period ended February 29, 2016 Elysee had net and comprehensive earnings of $391,851 as a result of net investment gains on its portfolio of $488,824. These financial statements, as well as our Audited Financial Statements for the year ended November 30, 2015, are available on SEDAR as well as on our recently updated web site at www.elyseedevelopment.com.On April 27, 2016 the Company paid a dividend of $0.02 per share for fiscal 2015 to shareholders of record as of April 20, 2016 for total proceeds of $425,359.48. This was an eligible dividend for Canadian tax purposes.As at May 20, 2016 our Net Asset Value ("NAV" per share was calculated as $0.42 per share. Moving forward, Elysee intends to update this NAV figure on a quarterly basis.NAV is a non-GAAP (generally accepted accounting principles) measure calculated as the value of total assets less the value of total liabilities divided by the total number of common shares outstanding as at a specific date. For the purpose of this calculation, share purchase warrants held by Elysee were valued based on their intrinsic value only. The warrants were not valued using the Black-Scholes model calculation, which would result in a higher value, as reported in our annual and quarterly financial statements. The term NAV does not have any standardized meaning according to GAAP and therefore may not be comparable to similar measures presented by other companies. There is no comparable GAAP measure presented in Elysee's consolidated financial statements and thus no applicable quantitative reconciliation for such non-GAAP financial measure. The Company believes that NAV can provide information useful to its shareholders in understanding its performance, and may assist in the evaluation of its business relative to that of its peer.FOR FURTHER INFORMATION, PLEASE CONTACT:Stuart RogersPresident & Chief Executive OfficerElysee Development Corp.Tel: (604) 689-1749Neither the TSX Venture Exchange nor its Regulation Services Provider (as the term is defined in the Policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.Caution Regarding Forward-Looking Statements - This news release contains certain forward-looking statements. These statements are subject to a number of risks and uncertainties. Actual results may differ materially from results contemplated by the forward-looking statements. When relying on forward-looking statements to make decisions, investors and others should carefully consider the foregoing factors and other uncertainties and should not place undue reliance on such forward-looking statements. The Company does not undertake to update any forward looking statements, oral or written, made by itself or on its behalf, except as required by applicable law.Source: Elysee Development Corp.
AXU: 2.15 (-0.02), ELC.VN: 0.340 (+0.020)

Alberta Star Announces Name Change to Elysee Development Corp.
ACCESSWIRE - Tue Jul 14, 12:25PM CDT
VANCOUVER, BC / ACCESSWIRE / July 14, 2015 / Alberta Star Development Corp. (TSXV: ASX) (OTC Pink: ASXSF) (FSE: QLD.F) (the "Company" announces that it intends to change its corporate name to "Elysee Development Corp.", effective July 15, 2015. The Company's stock symbol on the TSX Venture Exchange ("TSXV" will also change to "ELC". The name change was approved by shareholders, the board of directors and the TSXV. The Company will not undertake a change of business or consolidation of capital in conjunction with the change of corporate name. The new ISIN for the Company's listed shares is CA2907371058 and the new CUSIP is 290737105.
ASX.VN: 0.200 (unch)

Alberta Star Announces Normal Course Issuer Bid
GlobeNewswire - Mon May 04, 9:39AM CDT
Alberta Star Development Corp. (TSX-V:ASX) (OTC Pink: ASXSF) (Frankfurt:QLD) (the "Company", announces today its intention to make a normal course issuer bid (the "Bid" to purchase for cancellation, from time to time, as it considers advisable, up to 1,050,000 of its issued and outstanding common shares, being approximately 4.88% of the Company's currently outstanding common shares and approximately 6.2% of the Company's Public Float (as that term is defined in the policies of the TSX Venture Exchange (the "Exchange"). Commencement of the Bid is subject to the approval of the Exchange. The Bid will commence on May 7, 2015 and will terminate on May 6, 2016, or such earlier time as the Bid is completed or at the option of the Company. The Bid replaces the Company's current normal course issuer bid which expires on May 6, 2015. Jordan Capital Markets Inc. of Vancouver, British Columbia will conduct the Bid on behalf of the Company.
QLD: 84.45 (+0.08), ASX.VN: 0.200 (unch)

Alberta Star Options Archie Lake Property from NioCorp; Alberta Star to Subscribe for Private Placement for $1,540,000
Marketwired - Mon Oct 27, 7:04AM CDT
Alberta Star Development Corp. (TSX VENTURE: ASX)(OTCBB: ASXSF)(FRANKFURT: QLD) ("Alberta Star" is pleased to announce the signing of an option agreement (the "Option Agreement" with NioCorp Developments Ltd. ("NioCorp" on NioCorp's 100% owned Archie Lake property (the "Property" located in northern Saskatchewan. As part and parcel to the Option Agreement, Alberta Star will subscribe for $1,540,000 (the "Private Placement" in NioCorp's previously announced brokered financing of special warrants ("Special Warrants" at a price of $0.55 per Special Warrant. See NioCorp's news release dated October 22, 2014 for more information regarding the Special Warrants.
QLD: 84.45 (+0.08), ASX.VN: 0.200 (unch)

Alberta Star Begins Permitting for Winter Drill Program at Central Canada Gold Project, Ontario
Marketwired - Mon Oct 20, 10:42AM CDT
Alberta Star Development Corp. (TSX VENTURE: ASX) (OTCBB: ASXSF) (FRANKFURT: QLD) has commenced the permitting process for a winter drill program to be conducted at the Central Canada gold project in Ontario, which is the subject of an option agreement with TerraX Minerals Inc. announced February 14, 2014.
QLD: 84.45 (+0.08), ASX.VN: 0.200 (unch)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 342

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 178

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
Sungrow's Keeper Family: Revolutionizing C&I Energy Storage

Updated Category News Views 44

The Next Level in Energy Storage Solutions Well, folks, Sungrow's got something up its sleeve that's shaking up the energy storage scene. They're calling it the 'Keeper Family,' and if you’re deep into commercial and industrial (C&I) energy storage, this might just be your ticket to topping those profit charts. Launched at the Global Energy Pioneer Summit 2026, their...

Continue Reading
Biel Crystal Solidifies Position as Key iPhone UTG Supplier

Updated Category News Views 13

Biel Crystal Hones In On Foldable iPhone Tech Here's the lowdown: Apple's making waves with their first foldable phone, the iPhone Duo, and Biel Crystal? They're the rockstars cranking out that ultra-thin glass making it all possible. You might not have heard their name tossed around as much, but they're heavy hitters in the tech components scene. Biel Crystal's been...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 292

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 304

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
CureGene's CG-0416: Promising Weight Loss Breakthrough

Updated Category News Views 34

Game-Changer in Weight Management? Oh, the obesity world is buzzing, folks! There's some big noise coming from CureGene, and it's catching the attention of every lab-coat smarty in town. They just tossed out some preclinical data on CG-0416 at Obesity Week 2026 that could shake up how we tackle weight loss. Anyone still clinging to their old diet books might want to take...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 363

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Kayla Harrison Dominates UFC 334, Earns Big Win

Updated Category News Views 64

Kicking off UFC 334 with a bang, Kayla Harrison didn't just step into the Octagon—she bulldozed her way through Amanda Nunes to retain her Women's Bantamweight Championship. This showdown didn't just electrify New York's Madison Square Garden, it shook the entire MMA landscape. Harrison, the face of Monster Energy's athlete roster, wasn't content with just defending her...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 175

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading

Top 5 Most Recently Viewed Articles

Orion Corporation's Manager Transactions Highlight Executive Moves

Updated Category News Views 133

Understanding Orion Corporation's Executive Transactions Orion Corporation, a prominent player in the global pharmaceutical industry, has recently disclosed significant transactions involving its management, shedding light on financial movements that reflect company growth and strategy. Key Details on Managerial Transactions Recently, Orion Corporation reported under the...

Continue Reading
Congressman Questions SEC's 'Digital Asset Security' Definition

Updated Category News Views 150

Congressman Ritchie Torres Questions SEC's Use of Terminology Representative Ritchie Torres, a Democratic representative from New York, has recently shared his concerns about the phrase "digital asset security" as used by the U.S. Securities and Exchange Commission (SEC). He’s particularly interested in the legal basis and origins of this term. Congressional Dialogue...

Continue Reading
Investigating Claims for StubHub Investors: Your Options

Updated Category News Views 173

Investigation of Claims on Behalf of StubHub Investors Faruqi & Faruqi, LLP, a prominent name in national securities law, is currently looking into potential claims related to StubHub Holdings, Inc. (NYSE: STUB). This initiative aims to assist investors who might have faced losses due to the misleading statements made about the company's financial performance during its...

Continue Reading
Sarepta Therapeutics Faces Class Action Amid Safety Concerns

Updated Category News Views 256

Introduction to Sarepta Therapeutics Sarepta Therapeutics, Inc. is a biopharmaceutical company dedicated to developing innovative therapies for rare diseases, particularly those associated with genetic factors. The company is well-known for its gene therapy treatments and aims to revolutionize treatment options for patients with Duchenne muscular dystrophy and similar...

Continue Reading